Game-Changer for Rare Swelling Disorder

Big news for anyone dealing with hereditary angioedema (HAE): the FDA just approved Andembry, a once-a-month shot that actually prevents those scary swelling attacks before they start. It’s the first drug to target the real culprit (factor 12) and people in trials had way fewer attacks—like less than one a month! Plus, it’s got fewer side effects than older treatments. If you or someone you know struggles with HAE, this could be a total life upgrade. #HAE #RareDisease #FDAApproved #Health #BodyHealth